Polin L - Search Results

1

Antitumor efficacy of interleukin-2 alone and in combination with adriamycin and dacarbazine in murine solid tumor systems.

LoRusso PM, Aukerman SL, Polin L, Redman BG, Valdivieso M, Biernat L, Corbett TH. LoRusso PM, et al. Among authors: polin l. Cancer Res. 1990 Sep 15;50(18):5876-82. Cancer Res. 1990. PMID: 2393858

2

Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.

LoRusso P, Wozniak AJ, Polin L, Capps D, Leopold WR, Werbel LM, Biernat L, Dan ME, Corbett TH. LoRusso P, et al. Among authors: polin l. Cancer Res. 1990 Aug 15;50(16):4900-5. Cancer Res. 1990. PMID: 2165850

3

Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.

Mucci-LoRusso P, Polin L, Biernat LA, Valeriote FA, Corbett TH. Mucci-LoRusso P, et al. Among authors: polin l. Invest New Drugs. 1990 Aug;8(3):253-61. doi: 10.1007/BF00171834. Invest New Drugs. 1990. PMID: 2177044

4

Activity of batracylin (NSC-320846) against solid tumors of mice.

Mucci-LoRusso P, Polin L, Bissery MC, Valeriote F, Plowman J, Luk GD, Corbett TH. Mucci-LoRusso P, et al. Among authors: polin l. Invest New Drugs. 1989 Nov;7(4):295-306. doi: 10.1007/BF00173759. Invest New Drugs. 1989. PMID: 2557298

5

5-Fluorouracil containing combinations in murine tumor systems.

Corbett TH, Bissery MC, Mucci-LoRusso P, Polin L. Corbett TH, et al. Among authors: polin l. Invest New Drugs. 1989 Apr;7(1):37-49. doi: 10.1007/BF00178190. Invest New Drugs. 1989. PMID: 2661481 Review.

6

Chemotherapy of the squamous cell lung cancer LC-12 with 5-fluorouracil, cisplatin, carboplatin or iproplatin combinations.

Tapazoglou E, Polin L, Corbett TH, al-Sarraf M. Tapazoglou E, et al. Among authors: polin l. Invest New Drugs. 1988 Dec;6(4):259-64. doi: 10.1007/BF00173643. Invest New Drugs. 1988. PMID: 3068184

7

Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Corbett TH, Bissery MC, Wozniak A, Plowman J, Polin L, Tapazoglou E, Dieckman J, Valeriote F. Corbett TH, et al. Among authors: polin l. Invest New Drugs. 1986;4(3):207-20. doi: 10.1007/BF00179586. Invest New Drugs. 1986. PMID: 3546183

8

Comparative efficacy of DMP 840 against mouse and human solid tumor models.

LoRusso P, Demchik L, Dan M, Polin L, Gross JL, Corbett TH. LoRusso P, et al. Among authors: polin l. Invest New Drugs. 1995;13(3):195-203. doi: 10.1007/BF00873800. Invest New Drugs. 1995. PMID: 8729946

9

Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.

Merisko-Liversidge E, Sarpotdar P, Bruno J, Hajj S, Wei L, Peltier N, Rake J, Shaw JM, Pugh S, Polin L, Jones J, Corbett T, Cooper E, Liversidge GG. Merisko-Liversidge E, et al. Among authors: polin l. Pharm Res. 1996 Feb;13(2):272-8. doi: 10.1023/a:1016051316815. Pharm Res. 1996. PMID: 8932448

10

Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice.

Polin L, Valeriote F, White K, Panchapor C, Pugh S, Knight J, LoRusso P, Hussain M, Liversidge E, Peltier N, Golakoti T, Patterson G, Moore R, Corbett TH. Polin L, et al. Invest New Drugs. 1997;15(2):99-108. doi: 10.1023/a:1005856605726. Invest New Drugs. 1997. PMID: 9220288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters